table of content
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Molecular Diagnostics Overall Market Size
2.1 Global Lung Cancer Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Lung Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Lung Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Lung Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lung Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Cancer Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Lung Cancer Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Lung Cancer Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Lung Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Lung Cancer Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Lung Cancer Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Lung Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Lung Cancer Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Lung Cancer Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Lung Cancer Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Lung Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Lung Cancer Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Lung Cancer Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Lung Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Lung Cancer Molecular Diagnostics Market Size, 2018-2030
7 Lung Cancer Molecular Diagnostics Companies Profiles
7.1 Foundationmedicine
7.1.1 Foundationmedicine Company Summary
7.1.2 Foundationmedicine Business Overview
7.1.3 Foundationmedicine Lung Cancer Molecular Diagnostics Major Product Offerings
7.1.4 Foundationmedicine Lung Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Foundationmedicine Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Lung Cancer Molecular Diagnostics Major Product Offerings
7.2.4 Roche Lung Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Qiagen
7.3.1 Qiagen Company Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Lung Cancer Molecular Diagnostics Major Product Offerings
7.3.4 Qiagen Lung Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Qiagen Key News & Latest Developments
7.4 Liferiver
7.4.1 Liferiver Company Summary
7.4.2 Liferiver Business Overview
7.4.3 Liferiver Lung Cancer Molecular Diagnostics Major Product Offerings
7.4.4 Liferiver Lung Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Liferiver Key News & Latest Developments
7.5 Tellgen
7.5.1 Tellgen Company Summary
7.5.2 Tellgen Business Overview
7.5.3 Tellgen Lung Cancer Molecular Diagnostics Major Product Offerings
7.5.4 Tellgen Lung Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Tellgen Key News & Latest Developments
7.6 Genetech
7.6.1 Genetech Company Summary
7.6.2 Genetech Business Overview
7.6.3 Genetech Lung Cancer Molecular Diagnostics Major Product Offerings
7.6.4 Genetech Lung Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Genetech Key News & Latest Developments
7.7 Gpmedical
7.7.1 Gpmedical Company Summary
7.7.2 Gpmedical Business Overview
7.7.3 Gpmedical Lung Cancer Molecular Diagnostics Major Product Offerings
7.7.4 Gpmedical Lung Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Gpmedical Key News & Latest Developments
7.8 Sansure
7.8.1 Sansure Company Summary
7.8.2 Sansure Business Overview
7.8.3 Sansure Lung Cancer Molecular Diagnostics Major Product Offerings
7.8.4 Sansure Lung Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Sansure Key News & Latest Developments
7.9 Amoydx
7.9.1 Amoydx Company Summary
7.9.2 Amoydx Business Overview
7.9.3 Amoydx Lung Cancer Molecular Diagnostics Major Product Offerings
7.9.4 Amoydx Lung Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Amoydx Key News & Latest Developments
7.10 Mole
7.10.1 Mole Company Summary
7.10.2 Mole Business Overview
7.10.3 Mole Lung Cancer Molecular Diagnostics Major Product Offerings
7.10.4 Mole Lung Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Mole Key News & Latest Developments
7.11 Annoroad
7.11.1 Annoroad Company Summary
7.11.2 Annoroad Business Overview
7.11.3 Annoroad Lung Cancer Molecular Diagnostics Major Product Offerings
7.11.4 Annoroad Lung Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Annoroad Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
